Selected article for: "disease course and public health"

Author: Krejner-Bienias, Alicja; Grzela, Katarzyna; Grzela, Tomasz
Title: DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
  • Cord-id: 09587vgb
  • Document date: 2021_2_2
  • ID: 09587vgb
    Snippet: A novel coronavirus disease, COVID-19, has emerged as a global public health issue. Clinical course of disease significantly correlates with the occurrence of some comorbidities, among them type 2 diabetes. According to recent structural studies the dipeptidyl peptidase 4, a key molecule in the pathophysiology of diabetes, may influence the course of COVID-19. Since DPP4 inhibitors, gliptins, are widely used in diabetes patients, the exact role of DPP4 modulation in SARS-CoV-2 infection, at leas
    Document: A novel coronavirus disease, COVID-19, has emerged as a global public health issue. Clinical course of disease significantly correlates with the occurrence of some comorbidities, among them type 2 diabetes. According to recent structural studies the dipeptidyl peptidase 4, a key molecule in the pathophysiology of diabetes, may influence the course of COVID-19. Since DPP4 inhibitors, gliptins, are widely used in diabetes patients, the exact role of DPP4 modulation in SARS-CoV-2 infection, at least in that group, urgently needs to be clarified. In this short review, we discuss this issue with more detail.

    Search related documents:
    Co phrase search for related documents
    • accessory role play and acute respiratory syndrome: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace system and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and ada adenosine deaminase: 1
    • acute respiratory syndrome and adenosine deaminase: 1
    • acute respiratory syndrome and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ada adenosine deaminase and adenosine deaminase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • ada adenosine deaminase and liver kidney: 1
    • ada adenosine deaminase binding and adenosine deaminase: 1, 2
    • ada molecule and adenosine deaminase: 1